← Research analysis

Ancillaries & other

Insulin in bodybuilding: hypoglycaemia is the central danger

Compound: Insulin (non-medical use)Evidence base: LimitedUpdated: 2026-10-02Last reviewed: September 2026By: APEDRA editorial team

Insulin is used by some people for anabolic purposes. Case series describe severe and sometimes fatal hypoglycaemia; there are no controlled trials showing net benefit in healthy athletes.

Key points

  • Severe hypoglycaemia can occur rapidly and impair the ability to self-treat.
  • Case reports include seizures, brain injury and death.
  • Evidence for performance benefit in non-diabetic people is lacking.
  • Products sold online under this name have not been independently verified; label identity and concentration cannot be assumed.

What the literature shows

Evans and Lynch reported insulin misuse among bodybuilders and described associated hypoglycaemic episodes.

Reviews of non-medical insulin use highlight the absence of controlled efficacy data.

What remains unknown

  • Prevalence among Australian gym users.
  • Long-term metabolic consequences.

Safety and monitoring implications

  • Confusion, sweating, tremor or seizure is a medical emergency.
  • Never use alone; others need to know how to call for help.

Cited literature

  1. 1.Evans PJ, Lynch RM. (2003). Insulin as a drug of abuse in body building. British Journal of Sports Medicine. Find on PubMed
  2. 2.Anderson LJ, Tamayose JM, Garcia JM. (2018). Use of growth hormone, IGF-I, and insulin for anabolic purpose: pharmacological basis, methods of detection, and adverse effects. Molecular and Cellular Endocrinology. Find on PubMed

Community reports

Anecdotal — not scientific evidence

Lived experience is valuable context and often surfaces problems before the literature does. It is also uncontrolled, unverified and subject to bias, so it never overrides published findings here.

Editorial evidence status

Mixed

Community discussion of this compound is widespread, but no independently verified reports were available for this analysis. Anecdotes have not been invented or treated as clinical evidence.

Buying Insulin (non-medical use) in Australia: what to check first

APEDRA does not sell Insulin (non-medical use) or any other product, and takes no commission from suppliers. If you are researching where to buy it, the biggest practical risk is not the compound itself but what is actually in the bottle: under-dosing, substitution with a different compound, and contamination are all documented in independent testing of online research chemicals.

  • Ask for a batch-specific third-party lab report (HPLC/mass spectrometry), not a generic certificate.
  • Check independent review platforms, not only reviews hosted on the seller's own site.
  • Read the shipping, returns and refund policies before ordering.
  • Be wary of prices far below the market or exaggerated results claims.

Compare Australian vendors independently · how we assess suppliers

Terms used here are defined in our glossary, and the evidence-grading scale explains what this analysis's grade means. If you believe something here is wrong, tell us.

This analysis is educational. It is not medical advice, a dosing recommendation, or an endorsement of use. Speak with a qualified medical practitioner about your circumstances.